{
  "data": [
    {
      "projectCode": "R0639",
      "DxName&Title": "AAVF21 | AAV FGF21 - Transforming the chronic delivery of therapeutic proteins for metabolic diseases",
      "dxName": "Project Name2",
      "dxTitle": "AAV FGF21 - Transforming the chronic delivery of therapeutic proteins for metabolic diseases",
      "status": "Closed",
      "phaseCode": null,
      "category": "DRUG"
    },
    {
      "projectCode": "R0715",
      "DxName&Title": "AmyRsm | Development of an oral AmylinR agonist small molecule allows for FDC oral small molecule therapies with the ability to have bariatric surgery-like weight loss from a well-tolerated oral therapy with end organ protection.",
      "dxName": null,
      "dxTitle": "Development of an oral AmylinR agonist small molecule allows for FDC oral small molecule therapies with the ability to have bariatric surgery-like weight loss from a well-tolerated oral therapy with end organ protection.",
      "status": "Active",
      "phaseCode": "TV",
      "category": "test"
    },
    {
      "projectCode": "R0000",
      "DxName&Title": "AmylinR agonist small molecule allows for FDC oral small molecule therapies with the ability to have bariatric surgery-like weight loss from a well-tolerated oral therapy with end organ protection.",
      "dxName": null,
      "dxTitle": "Developmentof small molecule.",
      "status": "Active",
      "phaseCode": "UNKNOWN",
      "category": "FBP"
    }
  ]
}